Adipose Tissue Inflammation

In recent decades, obesity has become one of the most common metabolic diseases. Excess adiposity increases the risk of developing type 2 diabetes (T2D), cardiometabolic diseases, dyslipidemia, fatty liver, and several types of cancer [1]. Much progress has been made in understanding the major regulatory pathways underlying adipose tissue inflammation, which represent one the main drivers of adipose tissue dysfunction and, consequently, of obesity-associated metabolic alterations [2].

This Special Issue presents recent advances in understanding the molecular processes that take place in adipose tissue inflammation; moreover, it discusses the impact of adipose tissue inflammation on systemic metabolic alterations associated with excess adiposity, as well as its repercussion in several pathological conditions.

CITA DEL ARTÍCULO  Cells. 2023 May 26;12(11):1484.  doi: 10.3390/cells12111484